15/03/2019 18:59:57

INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, March 15, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AVEO Pharmaceuticals, Inc. (“AVEO” or “the Company”) (NASDAQ: AVEO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's shares between August 4, 2016 and January 31, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before April 26, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. The 2013 TIVO-3 trial for AVEO’s lead candidate drug, tivozanib, was not adequately designed to address concerns about survivability. The drug did not have sufficient survival data to gain FDA approval after its initial rejection. The lack of survival data put the Company at risk for additional FDA approval delays. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about AVEO, investors suffered damages.

Join the case

to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm

Brian Schall, Esq.,

Sherin Mahdavian, Esq.,

www.schallfirm.com

Office: 310-301-3335

Cell: 424-303-1964

info@schallfirm.com

SOURCE:

The Schall Law Firm

Schall Firm Logo 2.jpg

Related content
21 Mar - 
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Sharehold..
21 Mar - 
CLASS ACTION UPDATE for AVEO, STMP, AMR and MBT: Levi &..
21 Mar - 
DEADLINE NOTICE: Pawar Law Group Announces a Securities..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
UKTW I²P Celebrates First Successful Year of UK-TW Science Research Cooperation
2
ExCellThera announces clearance by FDA and Health Canada for ECT-001 in new clinical trials in United States and Canada for the treatment of leukemia
3
Reminder - Product Tanker, Crude Oil Tanker, LNG, LPG and Chemical Tankers Sector Panel Discussions With Major Shipping Company Executives
4
Invitation by Aperam S.A. to holders of its outstanding U.S.$300,000,000 0.625 per cent. Net Share Settled Convertible and/or Exchangeable Bonds due 2021 (ISIN XS1084287322) (the “Bonds”) convertible into common shares of Aperam S.A. to off
5
Philips expands its radiology solutions offering with advanced teleradiology services

Related stock quotes

Aveo Pharmaceuticals Inc 0,5733 -1.2% Stock price decreasing

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 March 2019 03:09:12
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190320.1 - EUROWEB2 - 2019-03-26 04:09:12 - 2019-03-26 03:09:12 - 1000 - Website: OKAY